Literature DB >> 26965717

Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.

Yue Ruan1, Hood Thabit2, Lalantha Leelarathna2, Sara Hartnell3, Malgorzata E Willinska1, Sibylle Dellweg4, Carsten Benesch4, Julia K Mader5, Manuel Holzer5, Harald Kojzar5, Mark L Evans2, Thomas R Pieber5, Sabine Arnolds5, Roman Hovorka6.   

Abstract

OBJECTIVE: To quantify variability of insulin requirements during closed-loop insulin delivery. RESEARCH DESIGN AND METHODS: We retrospectively analyzed overnight, daytime, and total daily insulin amounts delivered during a multicenter closed-loop trial involving 32 adults with type 1 diabetes. Participants applied hybrid day-and-night closed-loop insulin delivery under free-living home conditions over 12 weeks. The coefficient of variation was adopted to measure variability of insulin requirements in individual subjects.
RESULTS: Data were analyzed from 1,918 nights, 1,883 daytime periods and 1,564 total days characterized by closed-loop use over 85% of time. Variability of overnight insulin requirements (mean [SD] coefficient of variation 31% [4]) was nearly twice as high as variability of total daily requirements (17% [3], P < 0.001) and was also higher than variability of daytime insulin requirements (22% [4], P < 0.001).
CONCLUSIONS: Overnight insulin requirements were significantly more variable than daytime and total daily amounts. This may explain why some people with type 1 diabetes report frustrating variability in morning glycemia.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26965717     DOI: 10.2337/dc15-2623

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

Review 1.  Automated Insulin Delivery in Adults.

Authors:  Charlotte K Boughton; Roman Hovorka
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12-16       Impact factor: 4.741

Review 2.  Future of Automated Insulin Delivery Systems.

Authors:  Jessica R Castle; J Hans DeVries; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

Review 3.  Finding the right route for insulin delivery - an overview of implantable pump therapy.

Authors:  Lia Bally; Hood Thabit; Roman Hovorka
Journal:  Expert Opin Drug Deliv       Date:  2016-12-07       Impact factor: 6.648

4.  Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability.

Authors:  Anna M Lindmeyer; Juris J Meier; Michael A Nauck
Journal:  J Diabetes Sci Technol       Date:  2020-08-18

Review 5.  Automated insulin dosing systems: Advances after a century of insulin.

Authors:  Hood Thabit; Rayhan Lal; Lalantha Leelarathna
Journal:  Diabet Med       Date:  2021-09-28       Impact factor: 4.359

Review 6.  Automated insulin delivery systems: from early research to routine care of type 1 diabetes.

Authors:  Eric Renard
Journal:  Acta Diabetol       Date:  2022-08-22       Impact factor: 4.087

Review 7.  The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.

Authors:  Véronique Gingras; Nadine Taleb; Amélie Roy-Fleming; Laurent Legault; Rémi Rabasa-Lhoret
Journal:  Diabetes Obes Metab       Date:  2017-08-10       Impact factor: 6.577

8.  Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.

Authors:  Klemen Dovc; Charlotte Boughton; Martin Tauschmann; Hood Thabit; Lia Bally; Janet M Allen; Carlo L Acerini; Sabine Arnolds; Carine de Beaufort; Richard M Bergenstal; Fiona Campbell; Amy Criego; David B Dunger; Daniella Elleri; Mark L Evans; Elke Fröhlich-Reiterer; Sabine Hofer; Thomas Kapellen; Lalantha Leelarathna; Thomas R Pieber; Birgit Rami-Merhar; Viral N Shah; Judy Sibayan; Malgorzata E Wilinska; Roman Hovorka
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

Review 9.  Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.

Authors:  Julia Fuchs; Roman Hovorka
Journal:  Expert Rev Med Devices       Date:  2020-07-03       Impact factor: 3.166

Review 10.  Coming of age: the artificial pancreas for type 1 diabetes.

Authors:  Hood Thabit; Roman Hovorka
Journal:  Diabetologia       Date:  2016-06-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.